Regulator of G Protein Signaling 2 Deficiency Causes Endothelial Dysfunction and Impaired Endothelium-derived Hyperpolarizing Factor-mediated Relaxation by Dysregulating Gi/o Signaling-Reference-Cited by-同舟云学术

Regulator of G Protein Signaling 2 Deficiency Causes Endothelial Dysfunction and Impaired Endothelium-derived Hyperpolarizing Factor-mediated Relaxation by Dysregulating Gi/o Signaling

Published:2012-04 Issue:15 Volume:287 Page:12541-12549
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Osei-Owusu Patrick,Sabharwal Rasna,Kaltenbronn Kevin M.,Rhee Man-Hee,Chapleau Mark W.,Dietrich Hans H.,Blumer Kendall J.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference61 articles.

1. EDHF. Bringing the concepts together;Busse;Trends Pharmacol. Sci.,2002

2. The generation of nitric oxide by G protein-coupled receptors;Christopoulos;Life Sci.,1999

3. Endothelium-derived hyperpolarising factors and associated pathways. A synopsis;Edwards;Pflugers Arch. Eur. J. Physiol.,2010

4. Endothelium-derived vasoactive factors and hypertension. Possible roles in pathogenesis and as treatment targets;Félétou;Curr. Hypertens. Rep.,2010

5. Cellular signaling and NO production;Michel;Pflugers Arch. Eur. J. Physiol.,2010

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial fission inhibition protects against hypertension induced by angiotensin II;Hypertension Research;2024-02-21

2. Phosphodiesterases Mediate the Augmentation of Myogenic Constriction by Inhibitory G Protein Signaling and is Negatively Modulated by the Dual Action of RGS2 and 5;Function;2024

3. Anti-angiogenic mechanisms and serotonergic dysfunction in the Rgs2 knockout model for the study of psycho-obstetric risk;Neuropsychopharmacology;2023-10-17

4. Cardiac RGS Proteins in Human Heart Failure and Atrial Fibrillation: Focus on RGS4;International Journal of Molecular Sciences;2023-03-24

5. The therapeutic potential of targeting cardiac RGS4;Therapeutic Advances in Cardiovascular Disease;2023-01